Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyrine (MPTP) in the squirrel monkey-Reference-Cited by-同舟云学术

Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyrine (MPTP) in the squirrel monkey

Published:1984-02 Issue:2 Volume:292 Page:390-394
ISSN:0006-8993
Container-title:Brain Research
language:en
Short-container-title:Brain Research

Author:

William Langston J.,Forno Lysia S.,Rebert Charles S.,Irwin Ian

Publisher

Elsevier BV

Subject

Developmental Biology,Clinical Neurology,Molecular Biology,General Neuroscience

Reference7 articles.

1. A primate model of Parkinson's disease: selective destruction of substantia nigra, pars compacta dopaminergic neurons by N-methyl-4-phenyl-1,2,3,6- tetrahydropyridine;Burns,1983

2. N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, a parkinsonian syndrome causing agent in man and monkey, produces different effects in guinea pig and rat;Chiueh;Pharmacologist,1983

3. Chronic parkinsonism secondary to intravenous injection of meperidine analogues;Davis;Psychiat. Res.,1979

4. Pathology of Parkinson's Disease;Forno,1982

5. Pharmacological actions of 6-hydroxydopamine;Kostrzewa;Pharmacol. Rev.,1974

Cited by 756 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mitochondrial transfer of α-synuclein mediates carbon disulfide-induced mitochondrial dysfunction and neurotoxicity;Ecotoxicology and Environmental Safety;2024-08

2. Role of Animal Models in Parkinson's Disease (PD): What Role They Play in Preclinical Translational Research;CNS & Neurological Disorders - Drug Targets;2024-02

3. Continuous dopaminergic stimulation and the transition to using continuous drug delivery in Parkinson's disease—An introduction;International Review of Movement Disorders;2024

4. A sporadic Parkinson’s disease model via silencing of the ubiquitin–proteasome/E3 ligase component, SKP1A;Journal of Neural Transmission;2023-08-29

5. Utilizing mechanistic organic chemistry training to study drug metabolism in preclinical drug discovery/development;Medicinal Chemistry Research;2023-06-07